Suzhou Suncadia Biopharmaceuticals Co., Ltd.
65 active trials across 4 therapeutic areas
65
Active Trials
31
Phase 1
33
Phase 2
20
Phase 3
4
Therapeutic Areas
Portfolio Concentration: 88% of active trials in Oncology
Oncology
57 active / 64 total
Solid Tumor (Advanced)
18 active
21 total since 2015
NSCLC
9 active
3 Ph3
9 total since 2015
Colorectal Cancer
4 active
2 Ph3
5 total since 2015
Cholangiocarcinoma
4 active
1 Ph3
4 total since 2015
Ovarian Cancer
3 active
2 Ph3
3 total since 2015
Hepatocellular Carcinoma
3 active
1 Ph3
3 total since 2015
Cervical Cancer
2 active
1 Ph3
3 total since 2015
Esophageal Cancer
2 active
1 Ph3
3 total since 2015
Bladder Cancer
2 active
2 Ph3
2 total since 2015
Gastric Cancer
2 active
2 total since 2015
Triple Negative Breast Cancer
1 active
1 Ph3
2 total since 2015
Renal Cell Carcinoma
1 active
1 total since 2015
ALL
1 active
1 Ph3
1 total since 2015
Non-Hodgkin Lymphoma
1 active
1 Ph3
1 total since 2015
Head and Neck Cancer
1 active
1 total since 2015
SCLC
1 active
1 total since 2015
Breast Cancer
1 active
1 total since 2015
Multiple Myeloma
1 active
1 total since 2015
Immunology
4 active / 9 total
Urology
2 active / 2 total
Cardiovascular
1 active / 1 total
Click an indication to see competitive landscape (all sponsors in that indication).
Data: ClinicalTrials.gov (2015+)